Restart Anticoagulation in Patients With Spontaneous Intracerebral Hemorrhage and Mechanical Heart Valves

Overview

The investigators retrospectively reviewed the electronic medical records of the patients with spontaneous cerebral hemorrhage and mechanical valves from 2015 to 2020 in the second affiliated hospital of Zhejiang university medical college. Medical documents and patient data were reviewed, including patient age, gender, type of mechanical heart valve, replacement time, replacement site, underlying disease, anticoagulant drugs at admission, type of cerebral hemorrhage, treatment mode, time without anticoagulant, length of stay, mortality, etc

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: August 31, 2020

Interventions

  • Drug: Low molecular weight heparin
    • Anticoagulation therapy

Arms, Groups and Cohorts

  • cerebral hemorrhage
  • thromboembolism
  • no thromboembolism and cerebral hemorrhage

Clinical Trial Outcome Measures

Primary Measures

  • survival and death patients after follow-up investigation for 60 months
    • Time Frame: 2015-2020
    • the patients with spontaneous cerebral hemorrhage and mechanical valves in the second affiliated hospital of Zhejiang university medical college.

Participating in This Clinical Trial

Inclusion Criteria

  • patients with spontaneous cerebral hemorrhage and mechanical valves

Exclusion Criteria

  • age<18y
  • pregnant patients
  • death in 24 hours without anticoagulant

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Second Affiliated Hospital, School of Medicine, Zhejiang University
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • libin li, MD, Study Director, second affiliated hospital,school of medicine, zhejiang university,china
  • Overall Contact(s)
    • rubin luo, MD, +86057187783759, keyanlunli_zheer@163.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.